2012
DOI: 10.1016/j.bmcl.2012.08.057
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of highly water-soluble fibrate derivatives via BGLation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 35 publications
0
9
0
Order By: Relevance
“…Thus BGLation of fenofibrate may be beneficial to its ADME properties by ameliorating absorption and distribution. We also preliminarily confirmed that lipid-lowering effect of FF-BGL was not impaired using normal rats (Nemoto et al, 2012c). Further study on ADME profiles of FF-BGL is required to clarify comprehensive pharmacological benefit of BGLation of fenofibrate.…”
Section: Resultsmentioning
confidence: 48%
See 2 more Smart Citations
“…Thus BGLation of fenofibrate may be beneficial to its ADME properties by ameliorating absorption and distribution. We also preliminarily confirmed that lipid-lowering effect of FF-BGL was not impaired using normal rats (Nemoto et al, 2012c). Further study on ADME profiles of FF-BGL is required to clarify comprehensive pharmacological benefit of BGLation of fenofibrate.…”
Section: Resultsmentioning
confidence: 48%
“…Recently we succeeded in synthesizing a novel molecule, BGL003-conjugated fenofibrate (FF-BGL) (Fig. 1C) (Nemoto et al, 2012c). Fenofibrate is a popular peroxisome proliferator-activated receptor (PPAR) α agonist clinically used as an anti-hyperlipidemic drug and is known for its exceptionally hydrophobic character.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…1E) (Nemoto et al, 2012c;Miyamoto et al, 2012). We recently noticed that the BGL003-conjugated fenofibrate yielded an active form of fenofibrate, fenofibric acid (Fig.…”
Section: Resultsmentioning
confidence: 95%
“…We recently noticed that the BGL003-conjugated fenofibrate yielded an active form of fenofibrate, fenofibric acid (Fig. 1D) when administered in vivo, suggesting that BGL003 should be easily applicable to prodrug (Nemoto et al, 2012c). However, the safety of BGL003 will concern its success in future clinical development as BGL003 should be cleft off in vivo.…”
Section: Resultsmentioning
confidence: 99%